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Comparing verbal autopsy cause of death 
findings as determined by physician coding 
and probabilistic modelling: a public health 
analysis of 54 000 deaths in Africa and Asia
Background Coverage of civil registration and vital statistics varies 
globally, with most deaths in Africa and Asia remaining either unregis-
tered or registered without cause of death. One important constraint 
has been a lack of it–for–purpose tools for registering deaths and as-
signing causes in situations where no doctor is involved. Verbal autop-
sy (interviewing care–givers and witnesses to deaths and interpreting 
their information into causes of death) is the only available solution. 
Automated interpretation of verbal autopsy data into cause of death 
information is essential for rapid, consistent and affordable processing.
Methods Verbal autopsy archives covering 54 182 deaths from ive 
African and Asian countries were sourced on the basis of their geo-
graphical, epidemiological and methodological diversity, with exist-
ing physician–coded causes of death attributed. These data were uni-
fied into the WHO 2012 verbal autopsy standard format, and 
processed using the InterVA–4 model. Cause–speciic mortality frac-
tions from InterVA–4 and physician codes were calculated for each 
of 60 WHO 2012 cause categories, by age group, sex and source. Re-
sults from the two approaches were assessed for concordance and ra-
tios of fractions by cause category. As an alternative metric, the Wil-
coxon matched–pairs signed ranks test with two one–sided tests for 
stochastic equivalence was used.
Findings The overall concordance correlation coeficient between 
InterVA–4 and physician codes was 0.83 (95% CI 0.75 to 0.91) and 
this increased to 0.97 (95% CI 0.96 to 0.99) when HIV/AIDS and 
pulmonary TB deaths were combined into a single category. Over half 
(53%) of the cause category ratios between InterVA–4 and physician 
codes by source were not signiicantly different from unity at the 99% 
level, increasing to 62% by age group. Wilcoxon tests for stochastic 
equivalence also demonstrated equivalence.
Conclusions These indings show strong concordance between In-
terVA–4 and physician–coded indings over this large and diverse 
data set. Although these analyses cannot prove that either approach 
constitutes absolute truth, there was high public health equivalence 
between the indings. Given the urgent need for adequate cause of 
death data from settings where deaths currently pass unregistered, 
and since the WHO 2012 verbal autopsy standard and InterVA–4 
tools represent relatively simple, cheap and available methods for de-
termining cause of death on a large scale, they should be used as cur-
rent tools of choice to ill gaps in cause of death data.
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“Civil registration and vital statistics don’t quicken every-
one’s pulse.” So wrote Richard Horton [1] in summarising 
the irst Global Summit on Civil Registration and Vital Sta-
tistics (CRVS), held in Bangkok in April 2013. But, as was 
clear from that meeting, global understanding of public 
health depends on having an adequately comprehensive 
overview of cause–speciic mortality patterns at the popu-
lation level. Counting people and their life events is a big 
part of what needs to be done more effectively and com-
prehensively [2]; added to that is the need to attribute 
cause to deaths in a systematic, rapid, consistent and cost–
effective way.
Unsatisfactory progress in CRVS over recent decades lay at 
the heart of the four major objectives of the WHO Com-
mission on Information and Accountability for Women’s 
and Children’s Health (COIA) [3]. Accountability at every 
level ultimately depends on effectively counting individu-
als, and then making good use of those data. Implementa-
tion of COIA’s recommendations was entrusted to an inde-
pendent Evidence Review Group (iERG), which, in its 
2013 report [4], acknowledged that COIA’s recommenda-
tion on enhancing CRVS will be “dificult or impossible to 
achieve” by the target date of 2015. Instead, iERG now rec-
ommends making effective CRVS a post–2015 develop-
ment target. While there are evidently many practical ob-
stacles to achieving reliable CRVS on a global scale, one 
prerequisite component is the availability of it–for–pur-
pose tools for registering deaths and assigning cause of 
death. Such tools must be openly accessible, and be capa-
ble of delivering consistent and systematic mortality data 
in a timely and cost–effective manner.
Verbal autopsy (VA; interviewing a care–giver, relative or 
witness after a death, and using the interview material to 
determine cause of death) is seen as an essential interim 
approach for illing in some of the gaps in global knowl-
edge on cause–speciic mortality [5], which can otherwise 
only be estimated [6]. Although, in the long–term, one 
might hope for universal physician certiication of deaths, 
undertaken methodically and rigorously, this will not be 
the case for most deaths in Africa and Asia for the foresee-
able future. The immediate public health concern therefore 
is to establish VA methods for determining cause of death 
which are readily applicable on a large scale (including in 
routine CRVS processes) and provide suficient detail for 
effective health planning.
Verbal autopsy interview material has been collected in a 
variety of ways, and then interpreted into cause of death 
data by various methods. There has therefore been substan-
tial methodological heterogeneity involved, which can 
magnify existing uncertainties over cause–speciic mortal-
ity. The World Health Organization (WHO) released a new 
standard for VA data collection together with a revised set 
of cause of death categories (with equivalence to the Inter-
national Classiication of Diseases version 10 [ICD–10]) in 
2012 [7]. The process undertaken to streamline previous 
VA approaches into the new 2012 WHO VA standard is 
described in detail elsewhere [5].
Ways of interpreting VA data essentially fall into physician 
consideration of individual cases (physician–coded verbal 
autopsy, PCVA) or various mathematical approaches to au-
tomated processing of VA data. PCVA has been a de facto 
standard in many research settings, although associated de-
tails of methods and validity have not always been well es-
tablished [8] other than in speciic studies of hospital–
based deaths. PCVA is generally considered too slow and 
expensive for routine CRVS implementation, apart from 
the disadvantage of consuming often scarce physician time. 
A number of approaches to automated processing have 
been tried over the last decade or so; the currently most 
widely used is the InterVA suite of models that apply Bayes-
ian probabilistic modelling, and which have been in the 
public domain in various versions since 2005 (at www.in-
terva.net) [9]. Corresponding to the release of the 2012 
WHO VA standard, InterVA–4 was released in 2012, incor-
porating exactly the same range of input and output pa-
rameters as speciied by WHO [10].
Nevertheless, monitoring cause–speciic mortality is a 
long–term process, and so much of the existing VA mate-
rial which is archived in various places relects earlier stan-
dards and variations. It will be some time yet before any 
substantial body of VA data originally collected according 
to the provisions of the 2012 WHO VA standard becomes 
available. Our aim in this paper is to take VA archives from 
a variety of pre–2012 sources, which have also been as-
sessed by PCVA, convert them insofar as is possible into 
the 2012 WHO format, and compare the PCVA and Inter-
VA–4 indings. Our objective is primarily methodological. 
Rather than attempting to illuminate speciic epidemiolog-
ical indings, we evaluate the consistency between applying 
the 2012 WHO VA standard and the corresponding Inter-
VA–4 model to existing secondary data, and compare this 
with the primary physician–coded indings from the same 
data. The underlying consideration is the public health 
consistency and relevance of the two approaches – Inter-
VA–4 and PCVA – as a source of information for health 
planning in regions where routine cause–speciic mortality 
data are scarce. Many national and regional public health 
practitioners are posing the question as to whether they can 
reasonably rely on verbal autopsy surveillance with auto-
mated methods for assigning cause of death to monitor 
mortality patterns in the populations they serve: this study 
aims to answer that question.
Byass et al.
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using the conversion table speciied in the WHO documen-
tation. Age–groups corresponding to WHO 2012 catego-
ries (0–28 days, 1–11 months, 1–4 years, 5–14 years, 15–
49 years, 50–64 years and 65+ years) were used as the 
basis for analysis. Because of inherent uncertainty at the 
individual level in differentiating in many cases between 
the 01.03 HIV/AIDS and 01.09 pulmonary TB cause cat-
egories, both for InterVA–4 and PCVA, comparisons are 
presented with those categories separate and combined.
CSMFs were calculated for each source and cause of death, 
separately for InterVA–4 and PCVA indings. Concordance 
between InterVA–4 and PCVA CSMFs was measured using 
Lin’s concordance correlation coeficient [19], corrected 
and implemented for Stata [20]. As an alternative metric 
for assessing the equivalence of CSMFs from InterVA–4 and 
PCVA indings, we used the Wilcoxon matched–pairs 
signed ranks test and its two one–sided tests (TOST) vari-
ant for stochastic equivalence, with epsilon set to 3, as im-
plemented for Stata [21]. Ratios of CSMFs according to In-
terVA–4 and PCVA, by source, age–sex group and cause, 
were calculated together with 99% CIs, according to the 
Katz adjusted log method which permits the estimation of 
intervals around ratios where one side is zero [22]. CIs were 
calculated at the 99% level as hundreds of separate ratios 
were assessed. The objective of calculating these CIs was 
not so much for the sake of demonstrating statistical sig-
niicance, but rather to identify particular causes and age–
sex groups for which the CSMF ratios between interpreta-
tions by InterVA–4 and physicians were appreciably lower 
or higher than might be expected by chance, taking into 
account the number of cases involved.
No speciic ethical clearance was required for this study, 
which relied solely on the analysis of existing secondary 
data, without individually identiiable information. For the 
Kenya data set, in Kisumu, following cultural customs, 
compound heads provide written consent for all com-
pound members to participate in the HDSS activities. Any 
individual can refuse to participate at any time. The Kisumu 
DATA SOURCES AND METHODS
For the purposes of this comparison, we have selected sev-
eral VA data sets for secondary analyses on grounds of avail-
ability, variety of original VA procedures, coverage of di-
verse geographic locations and population groups, and 
with well–established local PCVA procedures. PCVA pro-
cedures varied slightly between sites, but for every site the 
consensus “main” or “underlying” cause was used here. The 
sources and characteristics of the data are shown in Table 
1. Data were sourced from Afghanistan, Bangladesh, Gha-
na, Kenya and South Africa. The original sources were of 
two main types, Demographic and Household Surveys 
(DHS) [17] and INDEPTH Network Health and Demo-
graphic Surveillance Systems (HDSS) [18] but there were 
also local variations in the details of VA procedures used 
within these two groupings. The locations also cover a wide 
range of HIV and malaria prevalences, which are the two 
causes of death which vary most markedly geographically. 
The two sites in South Africa are only 600 km apart and 
share a number of characteristics, but used different VA 
procedures. All of the PCVA results were reported using 
ICD–10 codes, enabling direct comparison with the Inter-
VA–4 outputs using the WHO 2012 ICD–10 cause catego-
ry deinitions.
Stata command iles were created for each site to extract as 
many as possible of the 2012 WHO InterVA indicators for 
each case (possible indicators total 244 across all age–sex 
groups, with the number of applicable questions for any 
particular death ranging from 54 to 181) from the various 
VA data sets. VA records which did not contain any symp-
tom data (ie, only identiication and background indica-
tors) or which did not include valid age and sex details 
were excluded. The VA data from each source were then 
processed using InterVA–4 (version 4.02) and the cause of 
death outputs processed into cause–speciic mortality frac-
tions (CSMF) as previously described [10]. PCVA outputs, 
speciied as ICD–10 codes, were categorised into the 2012 
WHO VA cause of death groups for comparative purposes, 
Table 1. Characteristics of the six data sources usedSource Type of daTa LocaTion popuLaTion group period deaThS occurred VerbaL auTopSy inSTrumenT deaThS coVered reference
Afghanistan DHS National cluster sample survey Entire 2005–2010 DDHS form 3349 [11]
Bangladesh DHS National cluster sample survey Women aged 12 to 49 y 1997–2001 DHS form 928 [12]
Ghana DHS National cluster sample survey Women aged 12 to 49 y 2002–2007 DHS form 4203 [13]
Kenya INDEPTH
HDSS
Surveillance site in Siaya County Entire 2003–2010 Adapted INDEPTH form 21 236 [14]
South Africa A INDEPTH
HDSS
Surveillance site in Bushbuckridge Entire 1992–2010 Locally adapted form 10 139 [15]
South Africa B INDEPTH
HDSS
Surveillance site in Kwa–Zulu Natal Entire 2000–2011 Adapted INDEPTH form 14 327 [16]
DHS – Demographic and Health Survey, HDSS – Health and Demographic Surveillance System
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HDSS protocol and consent procedures, including surveil-
lance and VA, were approved by KEMRI and CDC Institu-
tional Review Boards annually. For the South Africa A data 
set, surveillance–based studies in the Agincourt subdistrict 
were reviewed and approved by the Committee for Research 
on Human Subjects (Medical) of the University of the Wit-
watersrand, Johannesburg, South Africa (protocol M960720, 
renewed). Informed consent was obtained at the individual 
and household levels at every follow–up visit, whereas com-
munity consent from civic and traditional leadership was 
secured at the start of surveillance and reafirmed from time 
to time. For the South Africa B data set, ethical approval for 
the Africa Centre Demographic Surveillance was provided 
by the University of Kwa–Zulu–Natal Bio–Medical Research 
Ethics Committee (protocol E009/00).
RESULTS
Over the total of 54 182 VA records analysed, Table 2 
shows concordance correlation coeficients by data source 
and by age–group, both for the basic outputs and with the 
HIV and TB categories combined for sub–Saharan Africa. 
Figure 1 shows, for each WHO 2012 cause category and 
over all the six sources, a scatter plot of CSMFs from both 
InterVA–4 and PCVA interpretations. The corresponding 
concordance correlation coeficient was 0.831 (95% CI 
0.751–0.911), and this increased to 0.974 (95% CI 0.961–
0.987) when the 01.03 HIV/AIDS and 01.09 pulmonary 
TB cause categories were combined for sub–Saharan Africa. 
Table 3 shows results from the alternative Wilcoxon’s met-
ric for equivalence between CSMFs. Equivalence is repre-
sented by the large p values for the standard Wilcoxon’s 
signed rank test (not permitting rejection of the null hy-
pothesis of no difference) together with signiicant p values 
indicating that differences lay within the equivalence range.
Graphical presentations for each source separately, in a sim-
ilar format to Figure 1, are available in Online Supplemen-
tary Document, which also show WHO 2012 cause cate-
gories. Table 4 shows the CSMF for each WHO 2012 cause 
category and site, as determined by InterVA–4 and PCVA.
Using the CSMFs shown in Table 3 for each cause and 
source, CSMF ratios InterVA–4:PCVA were calculated with 
99% conidence intervals as a basis for comparison. These 
are tabulated fully in Additional File 1. Of the 320 source/
cause comparisons that were made, 171 (53.4%) of these 
Byass et al.
Table 2. Concordance correlation coeficients (CCC) for InterVA–4 [10] and physician–coded verbal autopsy (PCVA) interpretations 
of 54 182 verbal autopsies from 6 sourcesdeaThS baSic daTa hiV/aidS and puLmonary Tb caTegorieS combined
CCC 95% CI CCC 95% CI
Overall 54 182 0.831 0.751–0.911 0.974 0.961–0.987
Source:
Afghanistan 3349 0.625 0.464–0.787 – –
Bangladesh 928 0.720 0.580–0.860 – –
Ghana 4203 0.665 0.509–0.821 0.751 0.631–0.871
Kenya 21 236 0.854 0.785–0.923 0.923 0.885–0.960
South Africa A 10 139 0.912 0.868–0.956 0.947 0.922–0.972
South Africa B 14 327 0.588 0.415–0.760 0.990 0.985–0.995
Age–group:
0–28 d 1678 0.529 0.258–0.801 0.529 0.258–0.801
1–11 mo 5070 0.813 0.722–0.904 0.810 0.713–0.908
1–4 y 5123 0.886 0.824–0.948 0.909 0.857–0.961
5–14 y 1734 0.828 0.733–0.922 0.888 0.826–0.949
15–49 y 24 478 0.771 0.663–0.880 0.991 0.986–0.996
50–64 y 6239 0.784 0.667–0.902 0.981 0.969–0.993
65+ years 9860 0.846 0.760–0.931 0.895 0.835–0.956
CI – conidence interval, TB - tuberculosis
Figure 1. Correlation for cause–speciic mortality fractions 
(CSMF) for WHO 2012 causes of death from six data sources, 
as determined by InterVA–4 [10] and physician–coded verbal 
autopsy (PCVA) for 54 182 verbal autopsies, against the line of 
equivalence. Pink markers represent residual cause categories; 
blue markers represent speciic causes.
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ratios were not signiicantly different from unity at the 99% 
level.
CSMFs were similarly calculated by age–group and sex, 
across all sources. These results, in a similar format to Table 
2, are shown in Online Supplementary Document. A fur-
ther table in Online Supplementary Document shows 
CSMF ratios InterVA–4:PCVA, with 99% conidence inter-
vals, for each cause and age–sex group, over all data sourc-
es. Of the 530 age–sex/cause comparisons that were made, 
329 (62.1%) of these ratios were not signiicantly different 
from unity at the 99% level.
DISCUSSION
Our results show a generally good level of agreement be-
tween the InterVA–4 and PCVA approaches to the interpre-
tation of this large VA data set, over diverse populations. 
There are some important differences, discussed below, but 
nevertheless the two approaches achieved good public 
health equivalence, meaning that taking public health and 
health planning measures on the basis of either source would 
lead to similar conclusions. This concept of “public health 
equivalence” is very important in interpreting these indings. 
Development of VA methods in recent years has led to a sit-
uation in which public health practitioners in countries 
where deaths are not routinely registered with causes are 
posing important practical questions. They need to know 
whether they can reasonably rely on modern VA methods 
with automated interpretation to provide policy–relevant in-
formation on mortality patterns in a cost–effective manner. 
This is not just a matter of identifying major causes of death 
– it is equally critical, for example, to monitor causes that 
have become rare, such as measles, in order to be sure of the 
continued effectiveness of vaccination programmes. Previous 
work [23,24] has shown that InterVA–4 can be effectively 
operationalised at much lower cost than PCVA; here we 
demonstrate its functional equivalence to PCVA.
It is critical to realise that neither InterVA–4 nor PCVA, nor 
indeed the underlying VA data to which they have been 
applied, necessarily represent absolute truth (whatever that 
may be) in terms of cause of death. Cause of death assign-
ment is, at best, a mixture of science and judgement [25]. 
There is an extensive literature on comparisons between 
different methods for determining cause of death, which 
show substantial inter–method variations. A review of clin-
ical cause of death assignment and post–mortem indings 
found rates of discrepancies ranging from 30% to 63% 
across the 18 included studies [26]. Pre–mortem CT imag-
ing has been evaluated as only able to correctly identify 
66% of post–mortem examination causes of death [27]. In 
South Africa, an autopsy series on miners found that 51% 
of respiratory infections diagnosed at autopsy had not been 
noted clinically [28]. There is a clear need to improve fu-
ture VA methods by validating causes of death directly 
against post–mortem indings, but that is a major under-
taking given the widespread lack of autopsies undertaken 
in Africa and Asia [29]. Against this background of high 
discrepancy rates between post–mortem indings and oth-
er methods of assigning cause of death, the relatively good 
agreement between PCVA and InterVA–4 indings here is 
encouraging, even though both might differ from post–
mortem indings if those were available.
Attempts have been made to validate VA approaches in spe-
ciic studies with hospital or laboratory data [30]. Some 
speciic causes of death are amenable to this approach, for 
example by using particular data sets where ante–mortem 
HIV or sickle–cell status is documented [31,32]. A study 
from the Population Health Metrics Research Consortium 
recruited tertiary facility deaths across a range of hospital–
assigned pre–determined causes, which were followed up 
with VA interviews [33]. This data set was used to build 
new models for assigning cause of death, which were then 
tested together with other models and physician assigned 
causes in the same data set. Unsurprisingly, models built 
within this data set performed better in relation to the hos-
pital causes than either other models or physicians [34]. 
Further bench–testing of VA interpretation models showed 
roughly equivalent performance across various models 
when compared to PCVA as the reference standard [35]. 
By deining performance in relation to PCVA, however, 
these evaluations precluded comparison of public health 
consistency between models and physicians.
Analytical methods for comparing cause of death assign-
ment are not entirely straightforward, because of the gen-
eral uncertainty associated with cause of death, the interplay 
between precipitating and underlying causes, and the na-
ture of the data. Here we have concentrated on comparing 
CSMFs, since that is the primary outcome of interest from 
cause of death data in public health. The concordance cor-
relation coeficients and rank equivalence tests used here 
present accessible and convenient summary measures of 
how CSMFs from two different sources compared. For in-
Table 3. Statistical analysis of ranked cause-speciic mortality 
fractions, overall and by source, using the Wilcoxon matched–
pairs signed ranks test and its two one–sided tests variant for 
stochastic equivalenceSource WiLcoxon maTched pairS Signed rankS (p)
TWo one–Sided TeSTS VarianT for STochaSTic equiVaLence (ε = 3)pLoW, phigh
Overall 0.187 0.001, 0.047
Afghanistan 0.808 0.001, 0.003
Bangladesh 0.870 0.002, 0.001
Ghana 0.358 0.001, 0.007
Kenya 0.607 0.001, 0.007
South Africa A 0.262 0.001, 0.030
South Africa B 0.509 0.001, 0.010
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Table 4. Cause–speciic mortality fractions from 54 182 verbal autopsies, by WHO 2012 virtual autopsy cause category and data sourcecauSe of deaTh daTa Source
Afghanistan
(3349  
deaths)
Bangladesh
(928  
deaths)
Ghana
(4203  
deaths)
Kenya
(21 236 
deaths)
South Africa A
(10 139 
deaths)
South Africa B
(14 327 
deaths)
Inter-
VA–4*
PCVA Inter-
VA–4
PCVA Inter-
VA–4
PCVA Inter-
VA–4
PCVA Inter-
VA–4
PCVA Inter-
VA–4
PCVA
01.01 Sepsis (non–obstetric) 0.26 0.09 0.01 0.24 0.19 0.19 0.02 0.02
01.02 Acute resp. infect, incl. pneumonia 11.41 9.44 3.41 0.22 0.74 2.19 13.95 6.34 11.86 3.96 6.37 5.75
01.03 HIV/AIDS related death 0.89 0.12 22.73 22.65 17.85 27.82 24.09 24.01 19.41 45.33
01.04 Diarrhoeal diseases 5.06 5.85 1.37 4.20 1.20 5.04 2.41 4.19 2.02 3.91 0.57 2.22
01.05 Malaria 0.40 1.22 0.96 0.65 2.25 6.02 13.66 15.98 0.50 1.38 0.42 0.22
01.06 Measles 0.72 0.69 0.32 0.07 0.05
01.07 Meningitis and encephalitis 2.51 1.46 1.52 0.54 3.55 0.76 2.76 0.51 1.91 1.04 2.51
01.08, 10.05 Tetanus 0.01 0.02 0.01
01.09 Pulmonary tuberculosis 10.73 3.55 6.79 3.77 7.34 3.71 13.33 10.76 16.98 10.04 35.85 7.45
01.10 Pertussis 0.13 0.03 0.26 0.03
01.11 Haemorrhagic fever 0.06 0.01 0.01 0.01
01.99 Other and unspeciied infect dis 1.35 5.49 0.34 3.56 0.19 5.21 0.95 1.28 0.68 3.74 0.14 0.82
02.01 Oral neoplasms 0.35 0.06 1.19 0.32 0.46 0.00 0.14 0.21 0.02 0.11 0.06
02.02 Digestive neoplasms 2.90 4.18 6.07 3.56 3.42 0.43 1.90 1.47 2.75 0.96 1.40 0.78
02.03 Respiratory neoplasms 1.84 0.09 1.95 0.32 2.59 0.05 1.72 0.11 0.56 0.24 1.93 0.16
02.04 Breast neoplasms 0.47 0.60 2.55 1.08 2.18 1.28 0.07 0.22 0.68 0.31 0.23 0.21
02.05, 02.06 Reproductive neoplasms M,F 0.49 0.24 4.29 2.69 3.61 0.55 0.33 0.95 0.98 1.80 0.98 0.77
02.99 Other and unspeciied neoplasms 2.53 3.34 2.45 4.63 0.28 3.57 2.29 1.52 1.85 1.98 0.90 1.22
03.01 Severe anaemia 0.78 1.08 0.22 0.05 0.28 2.23 0.09 0.24
03.02 Severe malnutrition 3.95 2.21 0.68 0.04 0.72 4.07 0.50 1.16 0.39 0.52
03.03 Diabetes mellitus 1.21 4.03 1.39 0.86 0.13 1.12 0.57 1.13 1.80 1.39 1.68 2.35
04.01 Acute cardiac disease 0.83 1.70 1.90 2.69 0.47 0.64 0.37 0.04 0.43 0.32 0.44 1.20
04.03 Sickle cell with crisis 0.18 0.27 0.38
04.02 Stroke 4.28 4.87 7.92 6.79 1.23 4.12 1.23 1.34 2.10 4.36 3.30 5.42
04.99 Other and unspeciied cardiac dis. 3.27 9.44 9.49 3.88 4.58 6.23 3.74 0.63 2.66 5.32 3.99 5.19
05.01 Chronic obstructive pulmonary dis. 1.58 1.34 0.10 0.11 0.24 0.00 0.60 3.99 2.76 0.14 1.28 0.36
05.02 Asthma 1.29 0.84 0.78 1.40 6.11 0.90 0.34 0.45 0.69 0.33 0.69 0.52
06.01 Acute abdomen 2.98 0.36 3.66 0.32 8.12 0.90 3.07 0.30 1.09 0.15 1.04 0.01
06.02 Liver cirrhosis 0.75 0.57 3.88 3.99 0.78 2.17 0.63 0.57 0.52 1.43 0.28 1.26
07.01 Renal failure 0.26 0.51 3.23 1.94 1.27 0.98 0.47 0.99 0.14 0.41 0.51 0.65
08.01 Epilepsy 0.40 0.87 1.46 1.29 0.03 1.26 0.17 0.65 0.30 0.56 0.40 0.45
98 Other and unspeciied NCD 0.78 2.69 2.38 2.69 0.36 6.92 1.73 0.04 0.71 2.64 0.08 2.29
10.06 Congenital malformation 0.51 1.61 0.11 0.07 0.13 0.06 0.46 0.15 0.26
10.01 Prematurity 2.14 1.85 0.10 0.56 0.82 0.74 0.10 0.38
10.02 Birth asphyxia 3.17 0.30 0.93 0.39 0.53 0.24 0.24 0.29
10.03 Neonatal pneumonia 5.21 1.97 1.07 0.04 0.65 0.28 0.47 0.25
10.04 Neonatal sepsis 1.37 3.70 0.21 1.29 0.12 0.04 0.07 0.03
10.99 Other and unspeciied neonatal CoD 1.44 6.54 0.40 0.43 0.08 0.46 0.02 0.11
12.01 Road trafic accident 2.70 2.99 0.28 0.22 2.06 1.83 0.42 0.51 2.43 2.69 2.69 2.39
12.02 Other transport accident 0.06 0.02 0.01 0.70
12.03 Accid. fall 0.64 0.96 0.11 0.42 0.55 0.22 0.08 0.10 0.04 0.06
12.04 Accid. drowning and submersion 0.62 0.81 0.11 0.65 0.30 0.33 0.33 0.18 0.14 0.29 0.25 0.34
12.05 Accid. expos to smoke, ire & lame 0.26 0.60 0.29 0.65 0.09 0.17 0.22 0.26 0.37 0.38 0.28 0.17
12.06 Contact with venomous plant/animal 0.34 0.51 0.97 0.97 0.40 0.52 0.11 0.12 0.09 0.08 0.03
12.10 Exposure to force of nature 0.06 0.32 0.12 0.04 0.01 0.15 0.03
12.07 Accid. poisoning and noxious subs 0.04 0.12 0.03 0.02 0.19 0.06 0.31 0.13 0.16 0.05 0.15
12.08 Intentional self–harm 0.48 0.33 6.12 10.02 0.40 0.10 0.32 0.24 0.79 1.40 0.94 0.77
12.09 Assault 3.13 1.85 0.38 0.75 0.52 0.36 0.69 0.59 2.69 2.54 5.14 5.07
12.99 Other and unspeciied external CoD 0.29 3.46 1.83 0.31 0.09 1.15 0.44 0.92 0.07 0.70
09.01 Ectopic pregnancy 0.11 0.11 0.63 0.43 0.01 0.01 0.02 0.03 0.01
09.02 Abortion–related death 0.06 0.03 0.54 1.08 1.14 1.95 0.03 0.08 0.06 0.01 0.03
09.03 Pregnancy–induced hypertension 0.58 0.45 5.04 4.53 0.21 1.28 0.05 0.04 0.06 0.11 0.11 0.11
09.04 Obstetric haemorrhage 0.91 1.05 3.23 5.06 5.43 3.28 0.18 0.17 0.18 0.05 0.07 0.08
09.05 Obstructed labour 0.06 0.15 0.10 1.08 0.39 0.64
09.06 Pregnancy–related sepsis 0.15 0.03 1.08 0.75 0.83 1.00 0.05 0.07 0.02 0.08 0.03 0.04
09.07 Anaemia of pregnancy 0.04 0.06 0.74 1.72 0.21 1.78 0.04 0.02 0.02 0.03
09.08 Ruptured uterus 0.57 0.11 0.19 0.36 0.01 0.01
09.99 Other and unspeciied maternal CoD 0.01 0.42 0.71 5.60 0.42 3.66 0.05 0.09 0.01 0.25 0.02 0.20
99 Indeterminate 11.41 5.08 8.76 12.61 15.77 1.62 9.77 2.51 12.45 15.99 5.32 0.06
Overall 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
VA – verbal autopsy, PCVA – physician–coded verbal autopsy, M – male, F – female, CoD – cause of death
*InterVA–4 software [10].
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dividual cause comparisons by factors such as source, age–
group and sex, the ratio between CSMFs by the two meth-
ods provides insight on speciic aspects for comparison, and 
the conidence interval of that ratio is informative in decid-
ing whether or not differences are due to chance. It has been 
suggested that comparisons between cause of death meth-
ods should be corrected for chance agreement, which is 
more likely to occur in common causes [36]. However, from 
a public health perspective this is not necessarily appropri-
ate, since in practice agreement is generally accepted irre-
spective of the possibility that it was derived by chance.
The overall size and geographic diversity of the data pre-
sented here are important attributes. These VA data were 
not collected under carefully controlled and standardised 
procedures in order to minimise real–life sources of varia-
tion; this is a major strength of this study. The sources de-
liberately included a mix of high and low HIV and malaria 
settings, which are the two causes of highest variation in 
CSMF indings between speciic settings. In any cause of 
death data, a relatively small number of more common 
causes account for the majority of the deaths, followed by 
many causes accounting for small fractions in the remain-
der. Consequently it is only possible to evaluate cause of 
death methods thoroughly in data sets which are large 
enough to include realistic numbers of rarer causes. Glob-
ally, most unrecorded deaths occur in Africa and Asia, 
which are therefore the regions where VA methods are most 
urgently needed, and which are represented in these data. 
It must also be noted that inevitably none of these archived 
data sets were originally collected under the WHO 2012 
VA standard, and hence some degree of inter–site variation 
may have been introduced in the process of extracting the 
necessary VA indicator data.
One commonly contentious area in terms of cause of death 
is the interaction between HIV/AIDS and pulmonary TB. 
Three of the six data sources included substantial numbers 
of HIV/AIDS deaths during the periods covered by these 
data, and both InterVA–4 and PCVA indings relected that. 
A validation study for InterVA–4 in relation to HIV sero–
status showed high speciicity for HIV/AIDS as a cause of 
death (ie, relatively few false–positive HIV/AIDS cause as-
signments) but also showed considerably elevated mortal-
ity rates among sero–positives for causes such as pneumo-
nia and pulmonary tuberculosis [31]. Although ICD–10 
coding in principle requires the use of codes B20–B24 
where HIV and co–infections are involved, the extent to 
which this can reliably be implemented using VA methods 
is debatable, particularly if VA respondents are unaware of 
the HIV status of the deceased. In these analyses, there are 
clear differences between the two South African sources in 
this respect, with appreciably different proportions of 
deaths assigned as HIV/AIDS or tuberculosis. Conversely, 
in low HIV/AIDS or malaria settings, physicians may be re-
luctant to assign deaths to those causes. For example in the 
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Afghan data set, where very few HIV/AIDS deaths might 
be expected, HIV/AIDS was explicitly mentioned in four 
VA interviews, but this was not relected in the PCVA re-
sults, which never assigned HIV/AIDS as a cause of death.
Any cause of death assignment process, at the individual 
level, will involve some degree of uncertainty. Formal pro-
cedures for assigning cause of death, for example in oficial 
death certiicates, do not generally capture this uncertainty, 
but require the certiier to make a clear choice between pos-
sible causes [8]. Even if two certiiers are required to assess 
a case independently, as is often practised in PCVA, agree-
ment does not necessarily constitute truth. One factor that 
emerges clearly from these analyses is that in the PCVA 
indings there is a greater tendency for physicians to choose 
chapter residual categories (pink markers in Figure 1), 
rather than speciic causes (blue markers in Figure 1). This 
is evident from most of the pink markers lying below the 
line of equivalence, and is probably an expression of PCVA 
uncertainty. This was particularly evident in the neonatal 
age group, in addition to cross–over between neonatal sep-
sis and pneumonia categories, as seen in Online Supple-
mentary Document, Table s2, resulting in the lower cor-
relation observed for neonates. On the other hand, 
InterVA–4, by using a probabilistic model, computes a re-
sidual uncertainty for each case which is then expressed as 
an indeterminate component. By expressing uncertainty in 
this way, CSMFs for indeterminate causes may be greater 
according to InterVA–4.
CONCLUSIONS
Given the inherent dificulties and uncertainties involved 
in assigning cause of death, and the urgent need to imple-
ment large–scale, cost–effective CRVS procedures that in-
clude cause of death, it is clear that the priority for the fore-
seeable future in many low– and middle–income countries 
will be to undertake VA with automated cause of death as-
signment. We have shown here, using a large and diverse 
data set, that there is a strong correlation between in–coun-
try PCVA indings and outputs from the freely available In-
terVA–4 model, over a wide range of settings. Whilst ac-
cepting that neither PCVA nor InterVA–4 results 
necessarily represent absolute truth, and that there is a con-
tinuing search for improved methods for assigning causes 
of death, the use of InterVA–4 represents a low–resource 
and highly consistent strategy, which is a major advance on 
knowing almost nothing about cause of death proiles in 
many populations. The diversity of cause of death proiles 
which InterVA–4 produces across the various sources clear-
ly demonstrates that a standard model can be used success-
fully over a wide range of settings. InterVA–4, and the 
WHO 2012 VA standard with which it is fully compatible, 
should therefore be used as the currently available tools of 
choice for illing gaps in cause–speciic CRVS data.
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